Chison Medical's Self-Developed Breast AI Ultrasound Robot Secures Pioneering Medical Device Test Report

Deep News07-16 22:01

On July 16th, Chison Medical Technologies Co.,Ltd. (ASX: 688358) responded to investor inquiries via an interactive platform, announcing that its independently developed "Breast AI Ultrasound Robot" has obtained a medical device test report ahead of competitors.

This integrated solution features a touchscreen, an electric examination bed, a six-degree-of-freedom robotic arm, and automated ultrasound image transmission with AI-assisted image reading, enabling large-scale scanning and data tracking management. It establishes a comprehensive closed-loop management model covering "screening, referral, and treatment."

Regarding core medical robotics technologies, the company holds an industry-leading position in areas such as visual depth point cloud data segmentation algorithms, force control algorithms, and ultrasound image servo control algorithms. These technologies are deeply integrated into its "AI + Robotic Scanning" solution, offering an innovative pathway for mass screening of malignant tumors.

The company maintains a research and development-driven core strategy, focusing on a synergistic tripartite system comprising "AI Technology Ecosystem (Brain) – High-Definition Probes (Eyes) – Ultrasound Robot (Hands)." It continues to advance the strategic reserve and iterative development of extended ultrasound innovation projects.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1189914565?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-16 22:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189914565","market":"us","top_or_hot":-1,"title":"Chison Medical's Self-Developed Breast AI Ultrasound Robot Secures Pioneering Medical Device Test Report","media":"Deep News","content":"<p>On July 16th, <b>Chison Medical Technologies Co.,Ltd.</b> (<b>ASX: 688358</b>) responded to investor inquiries via an interactive platform, announcing that its independently developed \"Breast AI Ultrasound Robot\" has obtained a medical device test report ahead of competitors.<br><br>This integrated solution features a touchscreen, an electric examination bed, a six-degree-of-freedom robotic arm, and automated ultrasound image transmission with AI-assisted image reading, enabling large-scale scanning and data tracking management. It establishes a comprehensive closed-loop management model covering \"screening, referral, and treatment.\"<br><br>Regarding core medical robotics technologies, the company holds an industry-leading position in areas such as visual depth point cloud data segmentation algorithms, force control algorithms, and ultrasound image servo control algorithms. These technologies are deeply integrated into its \"AI + Robotic Scanning\" solution, offering an innovative pathway for mass screening of malignant tumors.<br><br>The company maintains a research and development-driven core strategy, focusing on a synergistic tripartite system comprising \"AI Technology Ecosystem (Brain) – High-Definition Probes (Eyes) – Ultrasound Robot (Hands).\" It continues to advance the strategic reserve and iterative development of extended ultrasound innovation projects.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chison Medical's Self-Developed Breast AI Ultrasound Robot Secures Pioneering Medical Device Test Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChison Medical's Self-Developed Breast AI Ultrasound Robot Secures Pioneering Medical Device Test Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-07-16 22:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On July 16th, <b>Chison Medical Technologies Co.,Ltd.</b> (<b>ASX: 688358</b>) responded to investor inquiries via an interactive platform, announcing that its independently developed \"Breast AI Ultrasound Robot\" has obtained a medical device test report ahead of competitors.<br><br>This integrated solution features a touchscreen, an electric examination bed, a six-degree-of-freedom robotic arm, and automated ultrasound image transmission with AI-assisted image reading, enabling large-scale scanning and data tracking management. It establishes a comprehensive closed-loop management model covering \"screening, referral, and treatment.\"<br><br>Regarding core medical robotics technologies, the company holds an industry-leading position in areas such as visual depth point cloud data segmentation algorithms, force control algorithms, and ultrasound image servo control algorithms. These technologies are deeply integrated into its \"AI + Robotic Scanning\" solution, offering an innovative pathway for mass screening of malignant tumors.<br><br>The company maintains a research and development-driven core strategy, focusing on a synergistic tripartite system comprising \"AI Technology Ecosystem (Brain) – High-Definition Probes (Eyes) – Ultrasound Robot (Hands).\" It continues to advance the strategic reserve and iterative development of extended ultrasound innovation projects.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AIBU","symbol_name":"Direxion Daily AI and Big Data Bull 2X Shares","start_time":0,"source_url":"","article_id":"1189914565","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189914565","pubTimestamp":1784210486,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"On July 16th, Chison Medical Technologies Co.,Ltd. (ASX: 688358) responded to investor inquiries via an interactive platform, announcing that its independently developed \"Breast AI Ultrasound Robot\"...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","161631":"人工智能","688358":"祥生医疗","AIBU":"Direxion Daily AI and Big Data Bull 2X Shares","03034":"南方纳指一百","QQQM":"NASDAQ100指数ETF-Invesco","07261":"华夏两倍做多纳斯达克100","MVPS":"Amplify Thematic All-Stars ETF","NJAN":"Innovator Growth-100 Power Buffer ETF - January","02834":"安硕纳指一百","QSWN":"Amplify BlackSwan Growth & Treasury Core ETF","QID":"两倍做空纳斯达克指数ETF-ProShares","MEDX":"HORIZON KINETICS MEDICAL ETF","BK1100":"医疗保健设备","MDEV":"First Trust Indxx Medical Devices ETF","QQA":"Invesco QQQ Income Advantage ETF","PTH":"Invesco Dorsey Wright Healthcare Momentum ETF","03455":"景顺QQQ","07266":"南方两倍做多纳指","AIFD":"TCW Artificial Intelligence ETF","BK1574":"生物医药B类股","LGHT":"LANGAR GLOBAL HEALTHTECH ETF","09996":"沛嘉医疗-B","ARTY":"ISHARES FUTURE AI & TECH ETF","LCLG":"Logan Capital Broad Innovative Growth ETF","NJUL":"Innovator Growth-100 Power Buffer ETF - July","QQQ":"纳指100ETF","KOMP":"SPDR S&P Kensho New Economies Composite ETF","BK1583":"高瓴概念","QDEC":"FT Vest Nasdaq-100 Buffer ETF - December","NBDS":"NEUBERGER BERMAN DISRUPTERS ETF","AGIX":"通用人工智能 ETF-AGIX","09086":"华夏纳指-U","07522":"FI二华夏纳一百","QLD":"2倍做多纳斯达克100指数ETF-ProShares","QTOC":"Innovator Growth Accelerated Plus ETF - October","ROBO":"全球机器人自动化ETF-ROBO","GDOC":"Goldman Sachs Future Health Care Equity ETF","VUSE":"Vident U.S. Equity Strategy ETF","QQQX":"Nuveen NASDAQ 100 Dynamic Overwrite","NOCT":"Innovator Growth-100 Power Buffer ETF - October","BK4593":"纳斯达克ETF","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","AGNG":"Global X Aging Population ETF","07568":"FI二南方纳指","GK":"AdvisorShares Gerber Kawasaki ETF","NEWZ":"StockSnips AI-Powered Sentiment US All Cap ETF","NAPR":"Innovator Growth-100 Power Buffer ETF - April","09834":"安硕纳指一百—U","TQQY":"GraniteShares YieldBOOST QQQ ETF","OGIG":"ALPS O'Shares Global Internet Giants ETF","GPIQ":"GOLDMAN SACHS NASDAQ 100 CORE PREMIUM INCOME ETF","03086":"华夏纳指","FWD":"AB DISRUPTORS ETF","TQQQ":"纳指三倍做多ETF","BK0251":"专用设备","RSPH":"Invesco S&P 500 Equal Weight Health Care ETF","SQQQ":"纳指三倍做空ETF","TARK":"Tradr 2X Long Innovation ETF","QMAR":"FT Vest Nasdaq-100 Buffer ETF - March","HART":"NYLI Healthy Hearts ETF","CPNQ":"Calamos Nasdaq-100 Structured Alt Protection ETF - December","PSQ":"做空纳斯达克100指数ETF-ProShares"},"translate_title":"Chison Medical自研乳腺AI超声机器人获得开创性医疗器械测试报告","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/2217a789e9cd2ae8aa241098b8275b12","symbols_score_info":{"159883":1,"161631":1,"688358":1,"07522":1,"AIBU":1,"NJAN":1,"TARK":1,"09834":1,"QMAR":1,"09086":1,"02834":1,"GDOC":1,"NBDS":1,"07266":1,"LGHT":1,"07568":1,"03455":1,"FWD":1,"ROBO":1,"AGIX":1,"AIFD":1,"HART":1,"03034":1,"OGIG":1,"QQQX":1,"PSQ":1,"NJUL":1,"GPIQ":1,"09996":1,"NOCT":1,"QSWN":1,"CHAT":1,"QID":1,"GK":1,"QQQ":1,"NEWZ":1,"ARTY":1,"RSPH":1,"LCLG":1,"MDEV":1,"MEDX":1,"NAPR":1,"PTH":1,"03086":1,"QQQM":1,"SQQQ":1,"07261":1,"QLD":1,"VUSE":1,"KOMP":1,"QQA":1,"AGNG":1,"QTOC":1,"QDEC":1,"CPNQ":1,"MVPS":1,"TQQY":1,"TQQQ":1},"content_text":"On July 16th, Chison Medical Technologies Co.,Ltd. (ASX: 688358) responded to investor inquiries via an interactive platform, announcing that its independently developed \"Breast AI Ultrasound Robot\" has obtained a medical device test report ahead of competitors.This integrated solution features a touchscreen, an electric examination bed, a six-degree-of-freedom robotic arm, and automated ultrasound image transmission with AI-assisted image reading, enabling large-scale scanning and data tracking management. It establishes a comprehensive closed-loop management model covering \"screening, referral, and treatment.\"Regarding core medical robotics technologies, the company holds an industry-leading position in areas such as visual depth point cloud data segmentation algorithms, force control algorithms, and ultrasound image servo control algorithms. These technologies are deeply integrated into its \"AI + Robotic Scanning\" solution, offering an innovative pathway for mass screening of malignant tumors.The company maintains a research and development-driven core strategy, focusing on a synergistic tripartite system comprising \"AI Technology Ecosystem (Brain) – High-Definition Probes (Eyes) – Ultrasound Robot (Hands).\" It continues to advance the strategic reserve and iterative development of extended ultrasound innovation projects.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1189914565","isCrawlerRequest":true}